E-labelling & Digital Transformation in Pharmacy

E-labelling, also known as electronic labelling, represents a significant step towards digital transformation in providing medication information electronically rather than through traditional paper information leaflets (PILs). At the 2023 FIP Congress in Brisbane, Australia, an insight board was convened to delve into the value, benefits, and barriers associated with e-labelling, its role in promoting health equity and equitable access to health information as well as the role of pharmacists in facilitating e-labelling adoption. Subsequently, a report summarising key insights and recommendations from the board was produced. FIP is hosting a digital event to build on the results of the report and to further explore e-labelling as a solution for improving accessibility and equity in health information, whilst also addressing challenges associated with the technology and regulatory aspects.
Moderator:
- Dalia Bajis, FIP Senior Programme Lead, FIP, The Netherlands
Facilitator:
- Nour Eltahla, FIP Equity and Humanitarian Programme Manager, FIP, The Netherlands
Panellists:
- Ema Paulino, President, National Pharmacy Association (ANF), Portugal
- Brett Simmonds, Chair FIP Regulators Advisory Group, Australia
- Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden